摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-叠氮基异喹啉 | 218301-40-7

中文名称
7-叠氮基异喹啉
中文别名
哌嗪,3-甲基-1-(3-甲基丁基)-
英文名称
7-azidoisoquinoline
英文别名
——
7-叠氮基异喹啉化学式
CAS
218301-40-7
化学式
C9H6N4
mdl
——
分子量
170.173
InChiKey
WWNQKPVKQSUGCZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    27.2
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:fc0a675f5600e9666b093467414b5bbf
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7-叠氮基异喹啉2-羟基-1,4-萘醌1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 乙腈 为溶剂, 反应 12.0h, 生成 1-(isoquinolin-7-yl)-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione
    参考文献:
    名称:
    Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO)
    摘要:
    Indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO), which mediate kynurenine pathway of tryptophan degradation, have emerged as potential new targets in immunotherapy for treatment of cancer because of their critical role in immunosuppression in the tumor microenvironment. In this investigation, we report the structural optimization and structure-activity relationship studies of 1-phenyl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as a new class of IDO1/TDO dual inhibitors. Among all the obtained dual inhibitors, 1-(3-chloro-4-fluorophenyl)-6-fluoro-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione (38) displayed the most potent IDO1 and TDO inhibitory activities with IC50 (half-maximal inhibitory concentration) values of 5 nM for IDO1 and 4 nM for TDO. It turned out that compound 38 was not a PAINS compound. Compound 38 could efficiently inhibit the biofunction of IDO1 and TDO in intact cells. In LL2 (Lewis lung cancer) and Hepa1-6 (hepatic carcinoma) allograft mouse models, this compound also showed considerable in vivo anti-tumor activity and no obvious toxicity was observed. Therefore, 38 could be a good lead compound for cancer immunotherapy and deserving further investigation.
    DOI:
    10.1016/j.ejmech.2020.112703
  • 作为产物:
    描述:
    7-氨基异喹啉三氟乙酸 、 sodium nitrite 、 sodium azide 作用下, 以 三氟乙酸 为溶剂, 反应 3.5h, 生成 7-叠氮基异喹啉
    参考文献:
    名称:
    Guanidine mimics as factor Xa inhibitors
    摘要:
    本申请描述了含氮杂环化合物及其衍生物的化学式I:或其药用可接受的盐形式,其中环D—E代表胍嘧啶模拟物,这些化合物可作为凝血因子Xa的抑制剂。
    公开号:
    US06339099B1
点击查看最新优质反应信息

文献信息

  • Guanidine mimics as factor Xa inhibitors
    申请人:DuPont Pharmaceuticals Company
    公开号:US06339099B1
    公开(公告)日:2002-01-15
    The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula I: or pharmaceutically acceptable salt forms thereof, wherein rings D—E represent guanidine mimics, which are useful as inhibitors of factor Xa.
    本申请描述了含氮杂环化合物及其衍生物的化学式I:或其药用可接受的盐形式,其中环D—E代表胍嘧啶模拟物,这些化合物可作为凝血因子Xa的抑制剂。
  • [EN] NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS<br/>[FR] NOUVEAUX IMITATEURS DE GUANIDINE UTILISES EN TANT QU'INHIBITEURS DU FACTEUR Xa
    申请人:DU PONT PHARMACEUTICALS COMPANY
    公开号:WO1998057951A1
    公开(公告)日:1998-12-23
    (EN) The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula (I) or pharmaceutically acceptable salt forms thereof, wherein rings D-E represent guanidine mimics, which are useful as inhibitors of factor Xa.(FR) Cette invention concerne des composés hétéroaromatiques contenant de l'azote et des dérivés de ces derniers de formule (I) ou des formes de sel pharmaceutiquement acceptables de ces derniers. Dans la formule les cycles D-E représentent des imitateurs de guanidine qui sont utiles en tant qu'inhibiteurs du facteur Xa.
    本申请描述了含氮杂环和其衍生物的化合物,其化学式为(I)或其药学上可接受的盐形式,其中环D-E代表胍基模拟物,可用作因子Xa的抑制剂。
  • Novel guanidine mimics as factor Xa inhibitors
    申请人:——
    公开号:US20020025963A1
    公开(公告)日:2002-02-28
    The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula I: 1 or pharmaceutically acceptable salt forms thereof, wherein rings D—E represent guanidine mimics, which are useful as inhibitors of factor Xa.
    本申请描述了公式I的含氮杂环及其衍生物,其中D-E环代表鸟氨酸类似物,其可作为因子Xa的抑制剂,或其药学上可接受的盐形式。
  • Novel guanidine mimics factor Xa inhibitors
    申请人:——
    公开号:US20030069258A1
    公开(公告)日:2003-04-10
    The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula I: 1 or pharmaceutically acceptable salt forms thereof, wherein rings D-E represent guanidine mimics, which are useful as inhibitors of factor Xa.
    本申请描述了式I的含氮杂环及其衍生物:1或其药学上可接受的盐形式,其中环D-E代表鸟氨酸类似物,可用作因子Xa的抑制剂。
  • Novel intermediates for guanidine mimics as factor Xa inhibitors
    申请人:——
    公开号:US20040063772A1
    公开(公告)日:2004-04-01
    The present application describes intermediates for nitrogen containing heteroaromatics and derivatives thereof of formula I: 1 or pharmaceutically acceptable salt forms thereof, wherein rings D—E represent guanidine mimics, which are useful as inhibitors of factor Xa.
    本申请描述了一些中间体,用于制备公式I:1中的含氮杂环和其衍生物,或其药学上可接受的盐形式,其中环D-E代表鸟氨酸类似物,这些中间体可用作因子Xa的抑制剂。
查看更多